Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03988543 · ClinicalTrials.gov registry record · NA

Bilingual Electronic Symptom Management Program Across Multi-site, Comprehensive Cancer Center

A NA study of Cancer, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
4,104
Enrollment target
1
Study location

NCT03988543 is a NA study of Cancer that has completed, run by Northwestern University. The registered enrollment target is 4,104 participants, above the 3,484-participant average among 615 other Cancer trials with a reported enrollment target (18% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03988543, a NA study of Cancer, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
4,104 participants
Enrollment target
1
Study location

Study Summary

Cancer, and cancer treatment, cause many symptoms that can negatively affect quality of life. Despite the development of improved symptom management interventions and several evidence- and consensus-based guidelines, their timely delivery remains uneven in the health care system. Our research center, Northwestern University IMPACT (NU IMPACT), builds upon an electronic health record (EHR)-integrated cancer symptom monitoring and management system, currently deployed by our health care system. We are testing the effectiveness of a system-wide symptom management intervention and the EHR-integrated enhanced care approach, which offers a more personalized symptom monitoring and management experience based on a person's unique needs and language (i.e., English or Spanish).

Conditions Studied

Interventions

  • BEHAVIORAL Patient Self-management

Study Locations (1)

Illinois

  • Northwestern Medicine - Chicago

Trial Details

FieldValue
Enrollment Target 4,104 participants
Start Date 2020-09-28
Est. Completion 2024-05-15
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT03988543

The ClinicalTrials.gov registry entry for NCT03988543 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 4,104 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,484-participant average among 615 other Cancer trials with a reported enrollment target (18% higher). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient Self-management is the first listed.

NCT03988543 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03988543 about?

NCT03988543 is a clinical study titled "Bilingual Electronic Symptom Management Program Across Multi-site, Comprehensive Cancer Center". Cancer, and cancer treatment, cause many symptoms that can negatively affect quality of life. Despite the development of improved symptom management interventions and several evidence- and consensus-based guidelines, their timely delivery remains uneven in the health care system. Our research center...

What is the current status of trial NCT03988543?

This trial is currently completed. It is a NA study. The enrollment target is 4,104 participants. The study started on 2020-09-28. Estimated completion is 2024-05-15.

What conditions does trial NCT03988543 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03988543?

The interventions under investigation include: Patient Self-management (BEHAVIORAL).

Who is sponsoring clinical trial NCT03988543?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03988543 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.